Synthesis of Aminoacyl-2-Cyanopyrrolidine Compounds and Their Inhibitory Effect on the DPP-4 Enzyme
Die Pharmazie · 2026
DOI: 10.31083/pharmazie53112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, 2026. Verfasst von Liyuan Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, 437100 Xianning, Hubei, China. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Pyrrolidines. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Department of Education Science and Technology Research Project, Hubei University of Science and Technology, Scientific Research Projects, Special Project on Diabetes and Angiopathy.
Abstract (Originalsprache)
Background:Diabetes mellitus is a major global health concern. DPP-4 (dipeptidyl peptidase-4) inhibitors containing a 2-cyanopyrrolidine scaffold are in clinical use; however, systematic evaluation of amides derived from amino acids adjacent to the N-2 position of GLP-1 (glucagon-like peptide-1) has not been reported.Methods:A total of eight 2-cyanopyrrolidine derivatives, grouped into three series, were synthesized from N-Boc-protected amino acids via condensation with 2-cyanopyrrolidine followed by deprotection. The compounds were characterized by nuclear magnetic resonance (NMR), elemental analysis, and mass spectrometry (MS). DPP-4 inhibitory activity was evaluated in vitro using a DPP-IV Glo™ assay, with sitagliptin as a control. IC50 (Half Maximal Inhibitory Concentration) values were determined from three independent replicates (n = 3) and calculated by nonlinear regression. Results:Compounds 4d, 4g, and 4h exhibited excellent DPP-4 inhibition, with IC50 values of 1.36 ± 0.09, 5.24 ± 0.31, and 4.83 ± 0.22 nM, respectively. Compound 4d (histidine) was more potent than sitagliptin (6.13 ± 0.42 nM). The bis-cyanopyrrolidine derivatives 4g and 4h also showed strong activity. The remaining compounds (4a–4c, 4e, 4f) displayed moderate inhibition (IC50 112–181 nM).Conclusions:Aminoacyl-2-cyanopyrrolidine derivatives bearing an imidazole or bis-cyanopyrrolidine structure are potent DPP-4 inhibitors. These findings highlight the importance of neighboring GLP-1 amino acid residues (positions 1 and 3) in inhibitor design. Further cellular and in vivo studies are warranted to evaluate the therapeutic potential of these compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, 437100 Xianning, Hubei, China.
- Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, 437100 Xianning, Hubei, China.
Förderung
- Hubei Provincial Department of Education Science and Technology Research Project
- Hubei University of Science and Technology, Scientific Research Projects
- Special Project on Diabetes and Angiopathy
- Special Research Project Funding for Key Pharmacy Disciplines in 2018
Zitieren
APA
Guo, L., Di, M., Dong, Z., Zhang, D., Zhu, X., Wu, S., & Liu, C. (2026). Synthesis of Aminoacyl-2-Cyanopyrrolidine Compounds and Their Inhibitory Effect on the DPP-4 Enzyme. Die Pharmazie. https://doi.org/10.31083/pharmazie53112
Vancouver
Guo L, Di M, Dong Z, Zhang D, Zhu X, Wu S, et al. Synthesis of Aminoacyl-2-Cyanopyrrolidine Compounds and Their Inhibitory Effect on the DPP-4 Enzyme. Die Pharmazie. 2026. doi:10.31083/pharmazie53112
BibTeX
@article{Guo2026,
author = {Guo, Liyuan and Di, Man and Dong, Zhiyan and Zhang, Da and Zhu, Xiaoqing and Wu, Shi and Liu, Chao},
title = {Synthesis of Aminoacyl-2-Cyanopyrrolidine Compounds and Their Inhibitory Effect on the DPP-4 Enzyme},
journal = {Die Pharmazie},
year = {2026},
doi = {10.31083/pharmazie53112}
}
EUVIMED